APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Busulfan Injection

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Busulfan Injection Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

Report ID 173973340327 December 2025189 pages

Choose your research edition.

Industry ResearchBusulfan Injection Industry Research Report 2026117 pages · $2,950 USDIndustry Growth & TrendsGlobal Busulfan Injection Industry Growth and Trends Forecast to 203299 pages · $3,450 USDMarket StructureGlobal Busulfan Injection Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032189 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Busulfan Injection Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal Busulfan Injection Market Analysis and Forecast 2026-2032196 pages · $4,950 USD

Market perspective

The global Busulfan Injection market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Busulfan Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Busulfan Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Busulfan Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Busulfan Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Busulfan Injection include Nexus, Otsuka Pharmaceutical, Pharmaceutics International, Inc, China Resources Double Crane Pharmaceutical Co., Ltd., Sagent(China)Pharmaceuticals Co.,Ltd., Qingdao Haida Technology Pharmaceutical Co., Ltd. and Zhejiang Huahai Pharmaceutical Co., Ltd., among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Busulfan Injection market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Busulfan Injection and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Busulfan Injection sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Busulfan Injection market size, projected growth trends, production technologies, key applications, and end-use industries.

Busulfan Injection Segment by Company

Nexus

Otsuka Pharmaceutical

Pharmaceutics International, Inc

China Resources Double Crane Pharmaceutical Co., Ltd.

Sagent(China)Pharmaceuticals Co.,Ltd.

Qingdao Haida Technology Pharmaceutical Co., Ltd.

Zhejiang Huahai Pharmaceutical Co., Ltd.

Busulfan Injection Segment by Type

Original Drugs

Generic Drugs

Busulfan Injection Segment by Application

Clinic

Hospital

Other

Busulfan Injection Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Busulfan Injection market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Busulfan Injection and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Busulfan Injection.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Busulfan Injection market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Busulfan Injection manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Busulfan Injection in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Busulfan Injection in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Busulfan Injection Industry Trends Table 2. Busulfan Injection Industry Drivers Table 3. Busulfan Injection Industry Opportunities and Challenges Table 4. Busulfan Injection Industry Restraints Table 5. Global Busulfan Injection Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Busulfan Injection Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Busulfan Injection Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global Busulfan Injection Sales Market Share by Manufacturers Table 9. Global Busulfan Injection Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Busulfan Injection Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Busulfan Injection Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Busulfan Injection Manufacturers, Product Type & Application Table 13. Global Busulfan Injection Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Busulfan Injection by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Original Drugs Table 17. Major Manufacturers of Generic Drugs Table 18. Global Busulfan Injection Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 19. Global Busulfan Injection Sales by Type (2021-2026) & (K Units) Table 20. Global Busulfan Injection Sales by Type (2027-2032) & (K Units) Table 21. Global Busulfan Injection Sales Market Share by Type (2021-2026) Table 22. Global Busulfan Injection Sales Market Share by Type (2027-2032) Table 23. Global Busulfan Injection Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 24. Global Busulfan Injection Revenue by Type (2021-2026) & (K Units) Table 25. Global Busulfan Injection Revenue by Type (2027-2032) & (K Units) Table 26. Global Busulfan Injection Revenue Market Share by Type (2021-2026) Table 27. Global Busulfan Injection Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of Clinic Table 29. Major Manufacturers of Hospital Table 30. Major Manufacturers of Other Table 31. Global Busulfan Injection Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 32. Global Busulfan Injection Sales by Application (2021-2026) & (K Units) Table 33. Global Busulfan Injection Sales by Application (2027-2032) & (K Units) Table 34. Global Busulfan Injection Sales Market Share by Application (2021-2026) Table 35. Global Busulfan Injection Sales Market Share by Application (2027-2032) Table 36. Global Busulfan Injection Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 37. Global Busulfan Injection Revenue by Application (2021-2026) & (K Units) Table 38. Global Busulfan Injection Revenue by Application (2027-2032) & (K Units) Table 39. Global Busulfan Injection Revenue Market Share by Application (2021-2026) Table 40. Global Busulfan Injection Revenue Market Share by Application (2027-2032) Table 41. Global Busulfan Injection Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 42. Global Busulfan Injection Sales by Region (2021-2026) & (K Units) Table 43. Global Busulfan Injection Sales Market Share by Region (2021-2026) Table 44. Global Busulfan Injection Sales Forecasted by Region (2027-2032) & (K Units) Table 45. Global Busulfan Injection Sales Forecasted Market Share by Region (2027-2032) Table 46. North America Busulfan Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 47. North America Busulfan Injection Sales by Country (2021-2026) & (K Units) Table 48. North America Busulfan Injection Sales by Country (2027-2032) & (K Units) Table 49. Europe Busulfan Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 50. Europe Busulfan Injection Sales by Country (2021-2026) & (K Units) Table 51. Europe Busulfan Injection Sales by Country (2027-2032) & (K Units) Table 52. Asia Pacific Busulfan Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 53. Asia Pacific Busulfan Injection Sales by Country (2021-2026) & (K Units) Table 54. Asia Pacific Busulfan Injection Sales by Country (2027-2032) & (K Units) Table 55. South America, Middle East and Africa Busulfan Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 56. South America, Middle East and Africa Busulfan Injection Sales by Country (2021-2026) & (K Units) Table 57. South America, Middle East and Africa Busulfan Injection Sales by Country (2027-2032) & (K Units) Table 58. Global Busulfan Injection Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 59. Global Busulfan Injection Revenue by Region (2021-2026) & (US$ Million) Table 60. Global Busulfan Injection Revenue by Region (2027-2032) & (US$ Million) Table 61. Global Busulfan Injection Revenue Market Share by Region (2021-2026) Table 62. Global Busulfan Injection Revenue Market Share by Region (2027-2032) Table 63. Nexus Company Information Table 64. Nexus Business Overview Table 65. Nexus Busulfan Injection Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 66. Nexus Busulfan Injection Product Portfolio Table 67. Nexus Recent Development Table 68. Otsuka Pharmaceutical Company Information Table 69. Otsuka Pharmaceutical Business Overview Table 70. Otsuka Pharmaceutical Busulfan Injection Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. Otsuka Pharmaceutical Busulfan Injection Product Portfolio Table 72. Otsuka Pharmaceutical Recent Development Table 73. Pharmaceutics International, Inc Company Information Table 74. Pharmaceutics International, Inc Business Overview Table 75. Pharmaceutics International, Inc Busulfan Injection Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. Pharmaceutics International, Inc Busulfan Injection Product Portfolio Table 77. Pharmaceutics International, Inc Recent Development Table 78. China Resources Double Crane Pharmaceutical Co., Ltd. Company Information Table 79. China Resources Double Crane Pharmaceutical Co., Ltd. Business Overview Table 80. China Resources Double Crane Pharmaceutical Co., Ltd. Busulfan Injection Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 81. China Resources Double Crane Pharmaceutical Co., Ltd. Busulfan Injection Product Portfolio Table 82. China Resources Double Crane Pharmaceutical Co., Ltd. Recent Development Table 83. Sagent(China)Pharmaceuticals Co.,Ltd. Company Information Table 84. Sagent(China)Pharmaceuticals Co.,Ltd. Business Overview Table 85. Sagent(China)Pharmaceuticals Co.,Ltd. Busulfan Injection Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 86. Sagent(China)Pharmaceuticals Co.,Ltd. Busulfan Injection Product Portfolio Table 87. Sagent(China)Pharmaceuticals Co.,Ltd. Recent Development Table 88. Qingdao Haida Technology Pharmaceutical Co., Ltd. Company Information Table 89. Qingdao Haida Technology Pharmaceutical Co., Ltd. Business Overview Table 90. Qingdao Haida Technology Pharmaceutical Co., Ltd. Busulfan Injection Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 91. Qingdao Haida Technology Pharmaceutical Co., Ltd. Busulfan Injection Product Portfolio Table 92. Qingdao Haida Technology Pharmaceutical Co., Ltd. Recent Development Table 93. Zhejiang Huahai Pharmaceutical Co., Ltd. Company Information Table 94. Zhejiang Huahai Pharmaceutical Co., Ltd. Business Overview Table 95. Zhejiang Huahai Pharmaceutical Co., Ltd. Busulfan Injection Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 96. Zhejiang Huahai Pharmaceutical Co., Ltd. Busulfan Injection Product Portfolio Table 97. Zhejiang Huahai Pharmaceutical Co., Ltd. Recent Development Table 98. Key Raw Materials Table 99. Raw Materials Key Suppliers Table 100. Busulfan Injection Distributors List Table 101. Busulfan Injection Customers List Table 102. Research Programs/Design for This Report Table 103. Authors List of This Report Table 104. Secondary Sources Table 105. Primary Sources List of Figures Figure 1. Busulfan Injection Product Image Figure 2. Global Busulfan Injection Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Busulfan Injection Market Size (2021-2032) & (US$ Million) Figure 4. Global Busulfan Injection Sales (2021-2032) & (K Units) Figure 5. Global Busulfan Injection Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Busulfan Injection Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Original Drugs Image Figure 9. Generic Drugs Image Figure 10. Global Busulfan Injection Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 11. Global Busulfan Injection Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global Busulfan Injection Sales Market Share by Type (2021-2032) Figure 13. Global Busulfan Injection Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 14. Global Busulfan Injection Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global Busulfan Injection Revenue Market Share by Type (2021-2032) Figure 16. Clinic Image Figure 17. Hospital Image Figure 18. Other Image Figure 19. Global Busulfan Injection Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 20. Global Busulfan Injection Sales Market Share 2021 VS 2025 VS 2032 Figure 21. Global Busulfan Injection Sales Market Share by Application (2021-2032) Figure 22. Global Busulfan Injection Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 23. Global Busulfan Injection Revenue Market Share 2021 VS 2025 VS 2032 Figure 24. Global Busulfan Injection Revenue Market Share by Application (2021-2032) Figure 25. North America Busulfan Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 26. North America Busulfan Injection Sales Market Share by Country (2021-2032) Figure 27. U.S. Busulfan Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 28. Canada Busulfan Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 29. Mexico Busulfan Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 30. Europe Busulfan Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 31. Europe Busulfan Injection Sales Market Share by Country (2021-2032) Figure 32. Germany Busulfan Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 33. France Busulfan Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 34. U.K. Busulfan Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 35. Italy Busulfan Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 36. Netherlands Busulfan Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 37. Asia Pacific Busulfan Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 38. Asia Pacific Busulfan Injection Sales Market Share by Country (2021-2032) Figure 39. China Busulfan Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 40. Japan Busulfan Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 41. South Korea Busulfan Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 42. Southeast Asia Busulfan Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 43. India Busulfan Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 44. Australia Busulfan Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 45. South America, Middle East and Africa Busulfan Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 46. South America, Middle East and Africa Busulfan Injection Sales Market Share by Country (2021-2032) Figure 47. Brazil Busulfan Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 48. South Africa Busulfan Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 49. Saudi Arabia Busulfan Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 50. Turkey Busulfan Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 51. Argentina Busulfan Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 52. UAE Busulfan Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 53. Egypt Busulfan Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 54. Chile Busulfan Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 55. Global Busulfan Injection Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Global Busulfan Injection Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 57. North America Busulfan Injection Revenue (2021-2032) & (US$ Million) Figure 58. North America Busulfan Injection Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 59. Europe Busulfan Injection Revenue (2021-2032) & (US$ Million) Figure 60. Europe Busulfan Injection Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Asia-Pacific Busulfan Injection Revenue (2021-2032) & (US$ Million) Figure 62. Asia-Pacific Busulfan Injection Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. South America, Middle East and Africa Busulfan Injection Revenue (2021-2032) & (US$ Million) Figure 64. South America, Middle East and Africa Busulfan Injection Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. Busulfan Injection Value Chain Figure 66. Manufacturing Cost Structure Figure 67. Busulfan Injection Production Mode & Process Figure 68. Direct Comparison with Distribution Share Figure 69. Distributors Profiles Figure 70. Years Considered Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • Original Drugs
  • Generic Drugs
Applications
  • Clinic
  • Hospital
  • Other
Companies covered
  • Nexus
  • Otsuka Pharmaceutical
  • Pharmaceutics International, Inc
  • China Resources Double Crane Pharmaceutical Co., Ltd.
  • Sagent(China)Pharmaceuticals Co.,Ltd.
  • Qingdao Haida Technology Pharmaceutical Co., Ltd.
  • Zhejiang Huahai Pharmaceutical Co., Ltd.

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Busulfan Injection Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Busulfan Injection Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Busulfan Injection Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Busulfan Injection Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Busulfan Injection Market Dynamics
  1. 2.1 Busulfan Injection Industry Trends
  2. 2.2 Busulfan Injection Industry Drivers
  3. 2.3 Busulfan Injection Industry Opportunities and Challenges
  4. 2.4 Busulfan Injection Industry Restraints
3 Busulfan Injection Market by Manufacturers
  1. 3.1 Global Busulfan Injection Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Busulfan Injection Sales by Manufacturers (2021-2026)
  3. 3.3 Global Busulfan Injection Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Busulfan Injection Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Busulfan Injection Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Busulfan Injection Manufacturers, Product Type & Application
  7. 3.7 Global Busulfan Injection Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Busulfan Injection Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Busulfan Injection Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Busulfan Injection Tier 1, Tier 2, and Tier 3
4 Busulfan Injection Market by Type
  1. 4.1 Busulfan Injection Type Introduction
  2. 4.1.1 Original Drugs
  3. 4.1.2 Generic Drugs
  4. 4.2 Global Busulfan Injection Sales by Type
  5. 4.2.1 Global Busulfan Injection Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Busulfan Injection Sales by Type (2021-2032)
  7. 4.2.3 Global Busulfan Injection Sales Market Share by Type (2021-2032)
  8. 4.3 Global Busulfan Injection Revenue by Type
  9. 4.3.1 Global Busulfan Injection Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Busulfan Injection Revenue by Type (2021-2032)
  11. 4.3.3 Global Busulfan Injection Revenue Market Share by Type (2021-2032)
5 Busulfan Injection Market by Application
  1. 5.1 Busulfan Injection Application Introduction
  2. 5.1.1 Clinic
  3. 5.1.2 Hospital
  4. 5.1.3 Other
  5. 5.2 Global Busulfan Injection Sales by Application
  6. 5.2.1 Global Busulfan Injection Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Busulfan Injection Sales by Application (2021-2032)
  8. 5.2.3 Global Busulfan Injection Sales Market Share by Application (2021-2032)
  9. 5.3 Global Busulfan Injection Revenue by Application
  10. 5.3.1 Global Busulfan Injection Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Busulfan Injection Revenue by Application (2021-2032)
  12. 5.3.3 Global Busulfan Injection Revenue Market Share by Application (2021-2032)
6 Global Busulfan Injection Sales by Region
  1. 6.1 Global Busulfan Injection Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Busulfan Injection Sales by Region (2021-2032)
  3. 6.2.1 Global Busulfan Injection Sales by Region (2021-2026)
  4. 6.2.2 Global Busulfan Injection Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Busulfan Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Busulfan Injection Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Busulfan Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Busulfan Injection Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Busulfan Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Busulfan Injection Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Busulfan Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Busulfan Injection Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Busulfan Injection Revenue by Region
  1. 7.1 Global Busulfan Injection Revenue by Region
  2. 7.1.1 Global Busulfan Injection Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Busulfan Injection Revenue by Region (2021-2026)
  4. 7.1.3 Global Busulfan Injection Revenue by Region (2027-2032)
  5. 7.1.4 Global Busulfan Injection Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Busulfan Injection Revenue (2021-2032)
  8. 7.2.2 North America Busulfan Injection Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Busulfan Injection Revenue (2021-2032)
  11. 7.3.2 Europe Busulfan Injection Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Busulfan Injection Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Busulfan Injection Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Busulfan Injection Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Busulfan Injection Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Nexus
  2. 8.1.1 Nexus Company Information
  3. 8.1.2 Nexus Business Overview
  4. 8.1.3 Nexus Busulfan Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Nexus Busulfan Injection Product Portfolio
  6. 8.1.5 Nexus Recent Developments
  7. 8.2 Otsuka Pharmaceutical
  8. 8.2.1 Otsuka Pharmaceutical Company Information
  9. 8.2.2 Otsuka Pharmaceutical Business Overview
  10. 8.2.3 Otsuka Pharmaceutical Busulfan Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Otsuka Pharmaceutical Busulfan Injection Product Portfolio
  12. 8.2.5 Otsuka Pharmaceutical Recent Developments
  13. 8.3 Pharmaceutics International, Inc
  14. 8.3.1 Pharmaceutics International, Inc Company Information
  15. 8.3.2 Pharmaceutics International, Inc Business Overview
  16. 8.3.3 Pharmaceutics International, Inc Busulfan Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Pharmaceutics International, Inc Busulfan Injection Product Portfolio
  18. 8.3.5 Pharmaceutics International, Inc Recent Developments
  19. 8.4 China Resources Double Crane Pharmaceutical Co., Ltd.
  20. 8.4.1 China Resources Double Crane Pharmaceutical Co., Ltd. Company Information
  21. 8.4.2 China Resources Double Crane Pharmaceutical Co., Ltd. Business Overview
  22. 8.4.3 China Resources Double Crane Pharmaceutical Co., Ltd. Busulfan Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 China Resources Double Crane Pharmaceutical Co., Ltd. Busulfan Injection Product Portfolio
  24. 8.4.5 China Resources Double Crane Pharmaceutical Co., Ltd. Recent Developments
  25. 8.5 Sagent(China)Pharmaceuticals Co.,Ltd.
  26. 8.5.1 Sagent(China)Pharmaceuticals Co.,Ltd. Company Information
  27. 8.5.2 Sagent(China)Pharmaceuticals Co.,Ltd. Business Overview
  28. 8.5.3 Sagent(China)Pharmaceuticals Co.,Ltd. Busulfan Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Sagent(China)Pharmaceuticals Co.,Ltd. Busulfan Injection Product Portfolio
  30. 8.5.5 Sagent(China)Pharmaceuticals Co.,Ltd. Recent Developments
  31. 8.6 Qingdao Haida Technology Pharmaceutical Co., Ltd.
  32. 8.6.1 Qingdao Haida Technology Pharmaceutical Co., Ltd. Company Information
  33. 8.6.2 Qingdao Haida Technology Pharmaceutical Co., Ltd. Business Overview
  34. 8.6.3 Qingdao Haida Technology Pharmaceutical Co., Ltd. Busulfan Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Qingdao Haida Technology Pharmaceutical Co., Ltd. Busulfan Injection Product Portfolio
  36. 8.6.5 Qingdao Haida Technology Pharmaceutical Co., Ltd. Recent Developments
  37. 8.7 Zhejiang Huahai Pharmaceutical Co., Ltd.
  38. 8.7.1 Zhejiang Huahai Pharmaceutical Co., Ltd. Company Information
  39. 8.7.2 Zhejiang Huahai Pharmaceutical Co., Ltd. Business Overview
  40. 8.7.3 Zhejiang Huahai Pharmaceutical Co., Ltd. Busulfan Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Zhejiang Huahai Pharmaceutical Co., Ltd. Busulfan Injection Product Portfolio
  42. 8.7.5 Zhejiang Huahai Pharmaceutical Co., Ltd. Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Busulfan Injection Value Chain Analysis
  2. 9.1.1 Busulfan Injection Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Busulfan Injection Production Mode & Process
  6. 9.2 Busulfan Injection Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Busulfan Injection Distributors
  9. 9.2.3 Busulfan Injection Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst